Download MendeleyChemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors.
Beroza, P., Crawford, J.J., Ganichkin, O., Gendelev, L., Harris, S.F., Klein, R., Miu, A., Steinbacher, S., Klingler, F.M., Lemmen, C.(2022) Nat Commun 13: 6447-6447
- PubMed: 36307407 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/s41467-022-33981-8
- Primary Citation Related Structures:
7S25, 7S26 - PubMed Abstract:
With the ever-increasing number of synthesis-on-demand compounds for drug lead discovery, there is a great need for efficient search technologies. We present the successful application of a virtual screening method that combines two advances: (1) it avoids full library enumeration (2) products are evaluated by molecular docking, leveraging protein structural information. Crucially, these advances enable a structure-based technique that can efficiently explore libraries with billions of molecules and beyond. We apply this method to identify inhibitors of ROCK1 from almost one billion commercially available compounds. Out of 69 purchased compounds, 27 (39%) have K i values < 10 µM. X-ray structures of two leads confirm their docked poses. This approach to docking scales roughly with the number of reagents that span a chemical space and is therefore multiple orders of magnitude faster than traditional docking.
- Discovery Chemistry, Genentech, South San Francisco, USA. berozap@gene.com.
Organizational Affiliation:
